Related Articles
Risk factors associated with secondary hyperparathyroidism in patients with chronic kidney disease
Molecular pathways associated with transcriptional alterations in hyperparathyroidism
Analysis of the correlation between serum resistin and the variability of erythropoietin responsiveness in patients with chronic kidney disease
Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway
Von Willebrand factor, ADAMTS13 activity, TNF-α and their relationships in patients with chronic kidney disease